Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 67.6 CNY -0.5%
Market Cap: 50.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

33.6
Current
34.3
Median
24.5
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
33.6
=
Enterprise Value
50.5B CNY
/
EBIT
1.5B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
27.4
2-Years Forward
EV/EBIT
22.4
3-Years Forward
EV/EBIT
19.6

See Also

Discover More